Received Jul 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (PRIORIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | J942L | — |
reconstituted with sterile water from Merck Sharp and amp;; This non-serious case was reported by a nurse via call center representative and described the occurrence of wrong solution used in drug reconstitution in a adult female patient who received MMR (Priorix) (batch number J942L, expiry date 08-NOV-2026) for prophylaxis. On 23-JUN-2025, the patient received Priorix. On 23-JUN-2025, an unknown time after receiving Priorix, the patient experienced wrong solution used in drug reconstitution (Verbatim: reconstituted with sterile water from Merck Sharp and amp;). The outcome of the wrong solution used in drug reconstitution was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 24-JUN-2025 Nurse practitioner explained that on June 23rd 2025, 2 patients were vaccinated with Priorix doses that were accidentally reconstituted with sterile water from Merck Sharp. Dohme vaccines instead of the Priorix corresponding diluent provided by Glaxo Smith Kline which led to wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. This case was linked with US2025079396, reported by same reporter different patient; Sender's Comments: US-GSK-US2025079396:same reporter /different patient